SCHEMBL5239018

SCHEMBL5239018

C[C@@]1(Cc2ccc(Cl)cc2)NC(=O)CCN(c2cccc3ccccc23)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 1/20 0.40
▸ TNKS2 Q9H2K2 1/20 0.40
▸ ELANE P08246 1/20 0.37
▸ ITGAL P20701 1/20 0.36
▸ FFAR2 O15552 1/20 0.36
▸ HTR1A P08908 3/20 0.36
▸ DRD2 P14416 3/20 0.36
▸ ADRA1D P25100 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ ADRA1B P35368 1/20 0.36
▸ P2RX7 Q99572 3/20 0.35
▸ DRD4 P21917 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5233691 0.89 P2RX7 (0.37) ELANEHTR1ADRD2ADRA1DHTR2A
SCHEMBL5229569 0.89 P2RX7 (0.37) ELANEHTR1ADRD2ADRA1DHTR2A
SCHEMBL5237680 0.74 CCR4 (0.32) ELANEHTR1ADRD2ADRA1DHTR2A
SCHEMBL6418686 0.64 HTR1A (0.64) HTR1ADRD2ADRA1DHTR2AADRA1A
Hydrochloric Acid SCHEMBL5233103 0.64 SIGMAR1 (0.40) TNKSHTR1ADRD2ADRA1DHTR2A
SCHEMBL1626105 0.64 POLB (0.49) ELANEHTR1AHTR2AP2RX7KDM4E
SCHEMBL1878252 0.63 POLB (0.47) ELANEHTR1ADRD2ADRA1DHTR2A
SCHEMBL13879502 0.62 ITGAL (0.61) ELANEITGALALDH1A1MAPT
SCHEMBL610033 0.61 DDAH1 (0.49) HTR1AHTR2AP2RX7KDM4EMEN1
SCHEMBL1828595 0.60 ELANE (0.43) ELANEITGALALDH1A1KMT2ADDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6452001-B2 1,4-DIAZEPINE-2-ONE DERIVATIVES AS NEUROKININ ANTAGONIST HOFFMANN-LA ROCHE INC. 2002-09-17 — — US claimed
US-20020010174-A1 Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation F. HOFFMANN-LA ROCHE AG (CH) 2002-01-24 — — US claimed
EP-1296961-B1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2007-02-14 — — EP disclosed
EP-1296961-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-02 — — EP disclosed
US-6452001-B2 1,4-DIAZEPINE-2-ONE DERIVATIVES AS NEUROKININ ANTAGONIST HOFFMANN-LA ROCHE INC. 2002-09-17 — — US disclosed
US-20020010174-A1 Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation F. HOFFMANN-LA ROCHE AG (CH) 2002-01-24 — — US disclosed
WO-2001090083-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010174-A1 Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation BDKRB2, NPSR1, BDKRB1 TNKS 2641/4885TNKS2 2872/4885ELANE 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback